Vertex Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
13.02.26
/
50%
€417.90
Target price
13.02.27
€455.79
Performance (%)
-10.29%
Price
17.04.26
€374.90
Summary
This prediction is currently active. The price of Vertex Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -10.29%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 0.739% | 0.739% |
| iShares Core DAX® | 3.593% | 3.931% |
| iShares Nasdaq 100 | 5.810% | 5.518% |
| iShares Nikkei 225® | 4.075% | 8.460% |
| iShares S&P 500 | 4.142% | 4.039% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $541.00 price target on by analysts at Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€391.10
22.01.26
22.01.26
€467.05
22.01.27
22.01.27
-4.14%
17.04.26
17.04.26
